PRESS RELEASE published on 02/21/2024 at 23:15, 1 year 9 months ago Think Research Announces a $5.0 Million Contract Expansion with a Global Pharmaceutical Company Think Research Corporation expands contract with global pharmaceutical client, adding $5.0 million agreement for Learning Management System and SaaS license. Total contract value reaches $15.0 million since May 2022 Think Research Corporation Global Pharmaceutical Client Contract Expansion Learning Management System SaaS License
BRIEF published on 02/21/2024 at 23:15, 1 year 9 months ago Think Research Corporation announces a $5 million contract expansion Think Research Corporation Saas LMS Pharmaceutical Contract Digital Health Solutions
PRESS RELEASE published on 02/16/2024 at 13:30, 1 year 9 months ago Think Research Enters into Definitive Agreement to be Acquired by Beedie Capital Think Research Corporation announces Beedie Investments Ltd. will acquire all common shares for $0.32 per Share in a strategic Transaction offering immediate liquidity to stakeholders and a significant premium. Special Committee and Board unanimously support the deal Acquisition Think Research Corporation Transaction Beedie Investments Ltd. Premium
PRESS RELEASE published on 01/18/2024 at 23:45, 1 year 10 months ago Think Research Announces Agreement for Subsequent Advance Under Existing Convertible Facility Think Research Corporation (TSXV:THNK) has announced the entry into an agreement for a $1 million convertible subsequent advance from Beedie Investments Ltd. The proceeds will be used for general and working capital purposes. The company intends to use the advance to support its mission of delivering knowledge-based digital health software solutions and organize the world's health knowledge. The advance forms part of the $25 million convertible facility with Beedie Capital previously announced on April 25, 2022. Think Research Corporation TSXV:THNK Beedie Investments Ltd Digital Health Software Solutions Convertible Subsequent Advance
PRESS RELEASE published on 12/16/2023 at 00:20, 1 year 11 months ago Think Research Announces Agreement for Subsequent Advance Under Existing Convertible Facility
PRESS RELEASE published on 12/07/2023 at 23:30, 1 year 11 months ago Think Research's Learning Management System to Support Healthcare Professional Education and Training
PRESS RELEASE published on 12/06/2023 at 23:00, 1 year 11 months ago Think Research Announces Grant of Equity Compensation Think Research Corporation (TSXV:THNK) granted 300,000 restricted share units (RSUs) to a certain officer pursuant to its Omnibus Equity Incentive Plan. Half will vest on Nov 30, 2024, and the balance on Nov 30, 2025. The company delivers knowledge-based digital health software solutions to over 13,000 facilities for healthcare professionals and governments Think Research Corporation TSXV:THNK Digital Health Software Solutions Restricted Share Units Equity Compensation
PRESS RELEASE published on 11/27/2023 at 13:00, 2 years ago Think Research Corporation Announces Third Quarter 2023 Results
PRESS RELEASE published on 11/22/2023 at 23:05, 2 years ago Think Research Announces Date of Third Quarter and Year-to-date 2023 Results and Conference Call Details
PRESS RELEASE published on 11/10/2023 at 23:35, 2 years ago Think Research Announces Agreement for Subsequent Advance Under Existing Convertible Facility
Published on 12/05/2025 at 02:35, 4 hours 33 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 8 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 3 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 8 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 17 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 53 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 8 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 23 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025